Abiopharma

News list

Anderson Chad 🟡 adjusted position in 708 shares of BLACKBAUD INC (BLKB) at $37.54 Transaction Date: May 04, 2026 | Filing ID: 000008

Full text

News bot May 6, 2026, 9:45 p.m.
🔍 Anderson Chad (Executive)

Company: BLACKBAUD INC (BLKB)

Report Date: 2026-05-04
Transaction Summary:
- Total transactions: 3
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 616
- Total shares sold: 1,324
Detailed Transactions and Holdings:
- Sold 1,137 shares of Common Stock at $37.54 per share (Direct)
  Date: 2026-05-04 | Code: F | equity_swap_involved: 0 | shares_owned_after: 68,645.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 616 shares of Common Stock (Direct)
  Date: 2026-05-04 | Code: A | equity_swap_involved: 0 | shares_owned_after: 69,261.00 | transaction_form_type: 4 | Footnotes: F2
- Sold 187 shares of Common Stock at $37.54 per share (Direct)
  Date: 2026-05-04 | Code: F | equity_swap_involved: 0 | shares_owned_after: 69,074.00 | transaction_form_type: 4 | Footnotes: F3
Footnotes:
- F1: Represents shares forfeited to the Issuer in connection with the satisfaction of tax liabilities incurred upon the vesting of restricted stock granted May 2, 2025.
- F2: Performance restricted stock units ("PRSUs") granted on May 2, 2025 that vested in full on May 4, 2026, based on the Issuer's overall financial performance for the period ended December 31, 2025, subject to continued employment.
- F3: Represents shares forfeited to the Issuer in connection with the satisfaction of tax liabilities incurred upon the vesting of PRSUs granted May 2, 2025.